Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Vitamin D-Binding Protein | 12 | 2021 | 83 | 4.83 | Why? |
| Vitamin D Deficiency | 9 | 2021 | 1782 | 2.99 | Why? |
| Vitamin D | 11 | 2021 | 2904 | 1.23 | Why? |
| Serum Albumin | 3 | 2019 | 571 | 1.08 | Why? |
| Macrophage-Activating Factors | 1 | 2021 | 5 | 0.92 | Why? |
| Interleukin-17 | 2 | 2017 | 602 | 0.92 | Why? |
| Chromosomes, Human, Y | 1 | 2020 | 24 | 0.87 | Why? |
| Bromcresol Green | 1 | 2018 | 2 | 0.75 | Why? |
| Bromcresol Purple | 1 | 2018 | 2 | 0.75 | Why? |
| Urinalysis | 2 | 2018 | 218 | 0.75 | Why? |
| Blood Group Antigens | 1 | 2020 | 202 | 0.69 | Why? |
| Electrophoresis, Capillary | 1 | 2017 | 39 | 0.69 | Why? |
| Polymorphism, Genetic | 7 | 2021 | 1074 | 0.69 | Why? |
| Diabetic Nephropathies | 2 | 2017 | 315 | 0.63 | Why? |
| Coloring Agents | 1 | 2017 | 116 | 0.63 | Why? |
| Albuminuria | 1 | 2017 | 164 | 0.62 | Why? |
| Intracranial Thrombosis | 1 | 2020 | 339 | 0.59 | Why? |
| Receptors, Urokinase Plasminogen Activator | 1 | 2017 | 252 | 0.54 | Why? |
| Protein Processing, Post-Translational | 1 | 2017 | 634 | 0.53 | Why? |
| Carbamates | 1 | 2017 | 485 | 0.52 | Why? |
| ABO Blood-Group System | 1 | 2021 | 995 | 0.47 | Why? |
| Kidney Failure, Chronic | 2 | 2017 | 3222 | 0.42 | Why? |
| Arthritis, Psoriatic | 1 | 2016 | 625 | 0.41 | Why? |
| Organometallic Compounds | 1 | 2012 | 206 | 0.39 | Why? |
| Limit of Detection | 1 | 2017 | 2698 | 0.38 | Why? |
| Iron Isotopes | 2 | 2017 | 3 | 0.36 | Why? |
| Nails | 3 | 2018 | 143 | 0.36 | Why? |
| Blood Proteins | 1 | 2012 | 551 | 0.35 | Why? |
| Parkinson Disease | 1 | 2020 | 1414 | 0.35 | Why? |
| Biological Products | 1 | 2021 | 2331 | 0.31 | Why? |
| Urea | 2 | 2017 | 228 | 0.30 | Why? |
| Venous Thrombosis | 1 | 2020 | 2739 | 0.28 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.24 | Why? |
| Genetic Background | 1 | 2020 | 11 | 0.23 | Why? |
| Renal Dialysis | 2 | 2018 | 4358 | 0.23 | Why? |
| Spectroscopy, Near-Infrared | 2 | 2018 | 137 | 0.21 | Why? |
| Creatinine | 3 | 2018 | 1443 | 0.21 | Why? |
| Humans | 42 | 2021 | 930598 | 0.20 | Why? |
| Hemoglobinuria | 1 | 2018 | 5 | 0.19 | Why? |
| Peroxidases | 1 | 2018 | 20 | 0.19 | Why? |
| Carboxylic Ester Hydrolases | 1 | 2018 | 16 | 0.19 | Why? |
| Immunoturbidimetry | 1 | 2018 | 8 | 0.19 | Why? |
| Survival | 1 | 2018 | 53 | 0.18 | Why? |
| Glycation End Products, Advanced | 1 | 2018 | 72 | 0.18 | Why? |
| Cation Transport Proteins | 1 | 2017 | 53 | 0.17 | Why? |
| Cardiovascular Diseases | 2 | 2020 | 11497 | 0.17 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.17 | Why? |
| Chemotaxis, Leukocyte | 1 | 2017 | 82 | 0.17 | Why? |
| Antibodies, Monoclonal | 1 | 2016 | 8041 | 0.17 | Why? |
| Vitiligo | 1 | 2018 | 76 | 0.17 | Why? |
| Reagent Strips | 1 | 2017 | 129 | 0.16 | Why? |
| Nephrotic Syndrome | 1 | 2019 | 146 | 0.16 | Why? |
| Oxides | 1 | 2017 | 77 | 0.16 | Why? |
| Spectroscopy, Fourier Transform Infrared | 1 | 2017 | 207 | 0.16 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.16 | Why? |
| Calibration | 1 | 2017 | 307 | 0.16 | Why? |
| Peptidyl-Dipeptidase A | 4 | 2021 | 9659 | 0.15 | Why? |
| Erythropoietin | 1 | 2017 | 167 | 0.15 | Why? |
| Metals | 1 | 2017 | 182 | 0.14 | Why? |
| Protective Factors | 1 | 2021 | 1720 | 0.14 | Why? |
| Hemoglobins | 2 | 2018 | 958 | 0.14 | Why? |
| Morbidity | 1 | 2021 | 1426 | 0.14 | Why? |
| Colorimetry | 1 | 2018 | 458 | 0.14 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.14 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.13 | Why? |
| Lipids | 1 | 2021 | 1079 | 0.13 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.13 | Why? |
| Glucose | 1 | 2018 | 573 | 0.13 | Why? |
| Renal Insufficiency, Chronic | 2 | 2017 | 2654 | 0.12 | Why? |
| Iron | 1 | 2018 | 619 | 0.12 | Why? |
| Diabetes Mellitus | 3 | 2018 | 8207 | 0.11 | Why? |
| Clinical Laboratory Services | 1 | 2018 | 781 | 0.11 | Why? |
| Models, Immunological | 1 | 2017 | 727 | 0.11 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.11 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.11 | Why? |
| Renal Insufficiency | 1 | 2018 | 810 | 0.11 | Why? |
| Prevalence | 3 | 2020 | 25773 | 0.10 | Why? |
| Anemia | 1 | 2017 | 789 | 0.10 | Why? |
| Keratins | 2 | 2018 | 33 | 0.10 | Why? |
| Drug Interactions | 1 | 2016 | 1653 | 0.09 | Why? |
| Haptoglobins | 2 | 2020 | 117 | 0.09 | Why? |
| Antioxidants | 1 | 2018 | 1593 | 0.09 | Why? |
| Disease Susceptibility | 1 | 2021 | 4002 | 0.09 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2021 | 3607 | 0.09 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.08 | Why? |
| Oxidative Stress | 1 | 2018 | 2050 | 0.08 | Why? |
| Glomerular Filtration Rate | 1 | 2012 | 1262 | 0.07 | Why? |
| Dermatology | 1 | 2021 | 1999 | 0.07 | Why? |
| Binding Sites | 1 | 2018 | 6201 | 0.07 | Why? |
| Child | 3 | 2021 | 70012 | 0.07 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.07 | Why? |
| Immunologic Factors | 1 | 2021 | 4206 | 0.07 | Why? |
| Skin Diseases | 1 | 2021 | 2509 | 0.07 | Why? |
| Glycosylation | 2 | 2018 | 1255 | 0.07 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.07 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.06 | Why? |
| Africa South of the Sahara | 2 | 2018 | 1335 | 0.06 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.06 | Why? |
| Mass Spectrometry | 2 | 2017 | 1165 | 0.06 | Why? |
| Hemochromatosis Protein | 1 | 2020 | 21 | 0.05 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.05 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.05 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.05 | Why? |
| INDEL Mutation | 1 | 2020 | 128 | 0.05 | Why? |
| Fructosamine | 1 | 2018 | 4 | 0.05 | Why? |
| Glycosuria | 1 | 2018 | 11 | 0.05 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.05 | Why? |
| Discriminant Analysis | 1 | 2018 | 170 | 0.05 | Why? |
| Glutathione Peroxidase | 1 | 2018 | 83 | 0.05 | Why? |
| Starvation | 1 | 2018 | 34 | 0.04 | Why? |
| Lipid Peroxidation | 1 | 2018 | 114 | 0.04 | Why? |
| Catalase | 1 | 2018 | 97 | 0.04 | Why? |
| Least-Squares Analysis | 1 | 2018 | 254 | 0.04 | Why? |
| Erythrocyte Count | 1 | 2018 | 137 | 0.04 | Why? |
| Transferrin | 1 | 2017 | 90 | 0.04 | Why? |
| Complement C3 | 1 | 2020 | 271 | 0.04 | Why? |
| Superoxide Dismutase | 1 | 2018 | 155 | 0.04 | Why? |
| Animals | 2 | 2017 | 78931 | 0.04 | Why? |
| Clinical Trials as Topic | 1 | 2016 | 7330 | 0.04 | Why? |
| Mice | 1 | 2017 | 21357 | 0.04 | Why? |
| Adult | 6 | 2021 | 244371 | 0.04 | Why? |
| Kidney Transplantation | 1 | 2017 | 5397 | 0.04 | Why? |
| Male | 8 | 2018 | 367725 | 0.04 | Why? |
| Italy | 1 | 2020 | 38444 | 0.04 | Why? |
| Biological Assay | 1 | 2018 | 367 | 0.04 | Why? |
| Gene Frequency | 1 | 2020 | 1210 | 0.04 | Why? |
| Dermatologic Agents | 1 | 2021 | 489 | 0.04 | Why? |
| Middle Aged | 6 | 2018 | 270681 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2016 | 9335 | 0.03 | Why? |
| Hydrogen-Ion Concentration | 1 | 2018 | 993 | 0.03 | Why? |
| Female | 6 | 2018 | 380317 | 0.03 | Why? |
| Alleles | 1 | 2020 | 1557 | 0.03 | Why? |
| Clinical Laboratory Techniques | 2 | 2018 | 23402 | 0.03 | Why? |
| Hydrogen Peroxide | 1 | 2018 | 680 | 0.03 | Why? |
| Public Health | 1 | 2018 | 16359 | 0.03 | Why? |
| Aged | 3 | 2018 | 215776 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.03 | Why? |
| Lung | 1 | 2021 | 31049 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2018 | 88759 | 0.03 | Why? |
| Proteins | 1 | 2018 | 921 | 0.03 | Why? |
| Glycated Hemoglobin A | 1 | 2018 | 1316 | 0.03 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.02 | Why? |
| Leukocyte Count | 1 | 2018 | 3178 | 0.02 | Why? |
| Cohort Studies | 1 | 2012 | 36005 | 0.02 | Why? |
| Genotype | 1 | 2020 | 4697 | 0.02 | Why? |
| Child, Preschool | 1 | 2012 | 36283 | 0.02 | Why? |
| Immunotherapy | 1 | 2021 | 2421 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2018 | 1956 | 0.02 | Why? |
| Poverty | 1 | 2018 | 2302 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2019 | 3755 | 0.02 | Why? |
| Point-of-Care Testing | 1 | 2018 | 2782 | 0.02 | Why? |
| Immunosuppressive Agents | 1 | 2021 | 6331 | 0.02 | Why? |
| Developing Countries | 1 | 2018 | 4283 | 0.01 | Why? |
| Adolescent | 1 | 2012 | 86841 | 0.01 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.01 | Why? |
| Epidemics | 1 | 2018 | 6407 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
Speeckaert's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(159)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_